These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2491457

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hydroxycholesterols in serum from hypercholesterolaemic patients with and without bile acid sequestrant therapy.
    van Doormaal JJ, Smit N, Koopman BJ, van der Molen JC, Wolthers BG, Doorenbos H.
    Clin Chim Acta; 1989 May 31; 181(3):273-9. PubMed ID: 2758681
    [Abstract] [Full Text] [Related]

  • 4. Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism.
    Einarsson K, Ericsson S, Ewerth S, Reihnér E, Rudling M, Ståhlberg D, Angelin B.
    Eur J Clin Pharmacol; 1991 May 31; 40 Suppl 1():S53-8. PubMed ID: 2044645
    [Abstract] [Full Text] [Related]

  • 5. Effects of colestipol hydrochloride on cholesterol and bile acids absorption in the rat intestinal tract.
    Fujihashi T, Munekiyo K, Meshi T.
    J Pharmacobiodyn; 1981 Aug 31; 4(8):552-8. PubMed ID: 7299619
    [Abstract] [Full Text] [Related]

  • 6. [Relation between serum lipoprotein metabolism and biliary lipid metabolism].
    Leiss O, von Bergmann K.
    Klin Wochenschr; 1983 Jun 15; 61(12):579-92. PubMed ID: 6876687
    [Abstract] [Full Text] [Related]

  • 7. A bioluminescence assay for total 3 alpha-hydroxy bile acids in serum using immobilized enzymes.
    Schoelmerich J, van Berge Henegouwen GP, Hofmann AF, DeLuca M.
    Clin Chim Acta; 1984 Feb 14; 137(1):21-32. PubMed ID: 6583028
    [Abstract] [Full Text] [Related]

  • 8. SK&F 97426-A a more potent bile acid sequestrant and hypocholesterolaemic agent than cholestyramine in the hamster.
    Benson GM, Alston DR, Bond BC, Gee AN, Glen A, Haynes C, Hickey DM, Iqbal S, Jackson B, Jaxa-Chamiec AA.
    Atherosclerosis; 1993 Jun 14; 101(1):51-60. PubMed ID: 8216502
    [Abstract] [Full Text] [Related]

  • 9. Cholestyramine treatment reduces postprandial but not fasting serum bile acid levels in humans.
    Angelin B, Björkhem I, Einarsson K, Ewerth S.
    Gastroenterology; 1982 Nov 14; 83(5):1097-101. PubMed ID: 7117793
    [Abstract] [Full Text] [Related]

  • 10. Bioluminescence measurement of primary bile acids using immobilized 7 alpha-hydroxysteroid dehydrogenase: application to serum bile acids.
    Roda A, Kricka LJ, DeLuca M, Hofmann AF.
    J Lipid Res; 1982 Dec 14; 23(9):1354-61. PubMed ID: 6962270
    [Abstract] [Full Text] [Related]

  • 11. Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100.
    Schmidt EB, Illingworth DR, Bacon S, Mahley RW, Weisgraber KH.
    Atherosclerosis; 1993 Jan 25; 98(2):213-7. PubMed ID: 8457260
    [Abstract] [Full Text] [Related]

  • 12. Colestipol at varying dosage intervals in the treatment of moderate hypercholesterolaemia.
    Lyons D, Webster J, Fowler G, Petrie JC.
    Br J Clin Pharmacol; 1994 Jan 25; 37(1):59-62. PubMed ID: 8148218
    [Abstract] [Full Text] [Related]

  • 13. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE.
    Artery; 1990 Jan 25; 17(5):281-8. PubMed ID: 2396902
    [Abstract] [Full Text] [Related]

  • 14. Bile acid sequestrants.
    Ast M, Frishman WH.
    J Clin Pharmacol; 1990 Feb 25; 30(2):99-106. PubMed ID: 2179278
    [Abstract] [Full Text] [Related]

  • 15. A bioluminescent assay for 12-alpha-hydroxy bile acids using immobilized enzymes.
    Schoelmerich J, Hinkley JE, Macdonald IA, Hofmann AF, DeLuca M.
    Anal Biochem; 1983 Aug 25; 133(1):244-50. PubMed ID: 6579865
    [Abstract] [Full Text] [Related]

  • 16. Bioluminescent assay for total bile acids in serum with use of bacterial luciferase.
    Styrélius I, Thore A, Björkhem I.
    Clin Chem; 1983 Jun 25; 29(6):1123-7. PubMed ID: 6573977
    [Abstract] [Full Text] [Related]

  • 17. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
    Grundy SM, Mok HY.
    J Lab Clin Med; 1977 Feb 25; 89(2):354-66. PubMed ID: 833472
    [Abstract] [Full Text] [Related]

  • 18. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
    Harvengt C, Desager JP.
    Clin Pharmacol Ther; 1976 Sep 25; 20(3):310-4. PubMed ID: 182429
    [Abstract] [Full Text] [Related]

  • 19. In vitro studies to investigate the reasons for the low potency of cholestyramine and colestipol.
    Benson GM, Haynes C, Blanchard S, Ellis D.
    J Pharm Sci; 1993 Jan 25; 82(1):80-6. PubMed ID: 8429497
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.